An aggressive global response, particularly over the past ten years, has finally pushed the HIV epidemic into decline. The number of new HIV infections is falling and more people than ever before have access to lifesaving antiretroviral treatment (ART). Breakthroughs in prevention, including vaginal microbicides, vaccine trials, and voluntary medical male circumcision have revived hopes of ending new infections.
While the epidemic is far from over, the right investments now could bring the goal of an “HIV-free generation” within reach for the first time in three decades. Yet, just as a strong push is needed, political will and financial resources are dwindling in the face of the global economic crisis. Thus, there is an urgent need to make existing funds go further, to maximize the effectiveness and efficiency of programs, and increase country ownership of the HIV response.
Good policies and a favorable policy environment are key to capitalizing on this moment of opportunity. We work with host-country partners to:
We also assist countries to improve health outcomes by addressing barriers due to stigma and discrimination, gender inequalities, socioeconomic status, operational issues, and other factors that prevent people from seeking the HIV prevention, treatment, and care services they need.
All our efforts are designed to increase country ownership of the AIDS response.
Biological, behavioral, and structural factors place certain key populations at higher risk for HIV transmission than other individuals. These key populations vary across regions and countries, but often include men who have sex with men (MSM), sex workers, people who inject drugs (PWID), detainees, and sexual partners from populations at lower risk of infection. Meeting the prevention, care, and treatment needs of these key populations and engaging them in the policy process is crucial to maximizing the impact of HIV policies and programs.
We support the implementation of PEPFAR guidance for key populations at higher risk by expanding evidence-based analysis and advocacy resources for PWID and MSM-related policies and programs as part of an overall effort to strengthen HIV policy and prevention.
High capacity for policy monitoring means being able to effectively and systematically collect, analyze, communicate, and use data related to the process and outcomes of health policy development and implementation. This helps ensure policies are based on sound evidence and better respond to the health needs of the population. HPP strengthens the capacity of governments, individuals, and civil society organizations to play a vital role in policy development, implementation, and monitoring to bolster national efforts in the response to HIV. We facilitate multi-stakeholder dialogues and foster strong relationships across sectors to effectively monitor the full policy process and use that information to improve policy development and implementation. This also enhances the accountability of government institutions to provide services and conditions specified in national and local laws, policies, and regulations.
Reducing stigma and discrimination is crucial to the success of HIV prevention, care, and treatment efforts. Integrating stigma-reduction and rights-based approaches into policies and interventions can reduce vulnerability to HIV and alleviate barriers to service access and use. Yet, stigma and discrimination remain seriously neglected issues in the global response to HIV. One of the main factors hindering efforts to focus attention and resources on stigma and discrimination has been the lack of concrete measurements with which to gauge the effects of stigma and discrimination and the impact of stigma-reduction efforts.
HPP supports greater integration of efforts to reduce stigma and discrimination into health policies and programs. Measuring stigma and developing training protocols in healthcare settings are a major focus within that broader effort.
Maximizing Efficiency and Effectiveness (E²)
The need to maximize the efficiency and effectiveness— also known as E² — of HIV programs has never been clearer. HPP defines E² as decreasing costs without decreasing the quality or quantity of the outputs and/or increasing outcomes without increasing long-term costs. We are working to develop an E² methodology that helps close the gaps in HIV financing and produce better program results.
The global HIV epidemic has fallen particularly hard on women and girls. In Sub-Saharan Africa, which is home to well over half (68%) of people living with HIV, women are more likely than men to contract HIV. This risk is heightened by gender inequalities, which expose women and girls to increased risk of sexual violence and make it harder for them to prevent HIV or access care, support, and treatment services.
With funding from PEPFAR, HPP is collaborating with the Public Health Institute to increase use of evidence in HIV policymaking and programming for women and girls under the What Works for Women and Girls program.
Policy Analysis and Advocacy Decision Models for Key Populations
The Health Policy Project HIV policy analysis and advocacy decision models are systematic structures and methodologies designed to help stakeholders create an inventory of country policies, analyze these policies against international best practices and human rights frameworks, assess policy implementation, and create a strategic advocacy plan.
Scaling Up Policies, Interventions, and Measurement for Stigma-Free HIV Prevention, Treatment, and Care Services
As part of an ongoing collaborative global effort to develop a standardized set of HIV-related stigma and discrimination measures for use in healthcare facilities, the Health Policy Project released a new working paper focusing on the scale-up of policies and interventions to reduce stigma in healthcare facilities.
Stigma and Discrimination: Key Barriers to Achieving Global Goals for Maternal Health and Elimination of New Child HIV Infections
This new Health Policy Project working paper examines the current evidence on stigma and discrimination and their negative impact on prevention of mother-to-child transmission (PMTCT), as well as the potential benefits of integrating PMTCT into antenatal care and maternal, neonatal, and child health services.
|The Health Policy Project is funded by the United States Agency for International Development (USAID) under Cooperative Agreement No.AID-OAA-A-10-00067, beginning September 30, 2010.It is implemented by the Futures Group, in collaboration with the Centre for Development||and Population Activities (CEDPA), Futures Institute, Partners in Population and Development Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), Research Triangle Institute (RTI) International, and the White Ribbon Alliance for Safe Motherhood (WRA).||The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.|